Colgate-Palmolive (NYSE: CL) awards stock, options to growth chief
Colgate-Palmolive (CL) granted its Chief Growth Officer, John Hazlin, 27,042 stock options and 3,908 restricted stock units on September 16, 2026. The options have an exercise price of $87.02 and expire in 2036, vesting in thirds. The RSUs vest in equal thirds over three years. Hazlin now holds 27,021 shares directly and 5,513 indirectly through the company's 401(k) plan.
How this was made
The 30-second read
Why it matters
The compensation grant is routine and unlikely to move the stock.
Market read
Limited relevance; primarily an insider compensation disclosure.
What to watch
Potential future dilution if options are exercised.
Background
The article reports a Form 4 filing detailing equity awards to Colgate-Palmolive's Chief Growth Officer.
Ticker impact
Chief Growth Officer John Hazlin received stock options for 27,042 shares and 3,908 RSUs on Sep 16, 2026.
No significant move expected.
Grant size is small relative to market cap; typical for executive compensation and unlikely to affect share price.
Market effects
None
None
None
Counterpoint
Even small grants can signal confidence in growth strategy.
Key entities
- CompanyColgate-Palmolive
Consumer goods company (NYSE: CL).
- ExecutiveJohn Hazlin
Chief Growth Officer receiving the awards.


